References
- Cervero F, Iggo A: The substantia gelatinosa of the spinal cord: a critical review. Brain 1980; 103: 717-72 https://doi.org/10.1093/brain/103.4.717
- Yoshimura M. Jessell TM: Primary afferent-evoked synaptic responses and slow potential generation in rat substantia gelatinosa neurons in vitro. J Neurophysiol 1989; 62: 96-108 https://doi.org/10.1152/jn.1989.62.1.96
- Yoshimura M, Nishi S: Primary afferent-evoked glycineand GABA-mediatcd IPSPs in substantia gcla tinosa neurones in the rat spinal cord in vitro. J Physiol 1995; 482 : 29-38 https://doi.org/10.1113/jphysiol.1995.sp020497
- Zhang HM, Li DP, Chen SR, Pan HL: M2, M3. and M4 receptor subtypes contribute to muscarinic potential ion of GABAergic inputs to spinal dorsal hom neur ons. J Pharmacal Exp Ther 2005; 313: 697-704
- Todd AJ, Spike RC: The localization of classical transminers and neuropeptides within neurons in laminae I-III of the mammalian spinal dorsal horn. Prog Neurobiol 1993; 41: 609-45 https://doi.org/10.1016/0301-0082(93)90045-T
- Todd AJ. McKenzie J: GABA-immunoreactive neurons in the dorsal horn of the rat spinal cord. Neuroscience 1989; 31: 799-806 https://doi.org/10.1016/0306-4522(89)90442-9
-
Bowery NG, Hudson AL, Price GW:
$GABA_A$ andGABA_B$ receptor site distribution in the rat central nervous system. Neuroscience 1987; 20: 365-83 https://doi.org/10.1016/0306-4522(87)90098-4 - Sousa AM, Prado WA: The dual effect of a nitric oxide donor in nociception. Brain Res 2001; 897 : 9-19 https://doi.org/10.1016/S0006-8993(01)01995-3
- Pyne NJ, Arshavsky V, Lochhead A: cGMP signal termination. Biochem Soc Trans 1996; 24: 1019-22 https://doi.org/10.1042/bst0241019
- Beavo JA: Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995; 75: 725-48 https://doi.org/10.1152/physrev.1995.75.4.725
- BooleIl M, Gepi-Attee S, Gingell JC, Allen MJ: Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Ural 1996; 78: 257-61 https://doi.org/10.1046/j.1464-410X.1996.10220.x
- Araiza-Saldana CI. Reyes-Garcia G. Bermudez-Ocana DY, Perez-Sevcriano F. Granados-Soto V: Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats. Eur J Pharmacol 2005; 527: 60-70 https://doi.org/10.1016/j.ejphar.2005.10.016
- Yoon MH, Bae HB, Shin DJ, Kim CM, Jeong ST, Kim SJ, et al: Evaluation for the effects of intrathecal sildenafil on the formalin- and thermal-induced nociception of rats. Korean J Pain 2006; 19: 17-21 https://doi.org/10.3344/kjp.2006.19.1.17
- Lee HG. Jeong CY, Yoon MH, Kim WM, Shin SH, Kim YO, et al: The role of opioid recep tor on the analgesic action of intrathecal sildenafil in rats. Korean J Pain 2007; 20: 21-5 https://doi.org/10.3344/kjp.2007.20.1.21
- Saransaari P, Oja SS: Modulation of GABA release by second messenger substances and NO in mouse brain stem slices under normal and ischemic conditions. Neurochem Res 2006; 31: 1317-25 https://doi.org/10.1007/s11064-006-9174-z
- Saransaari P, Oja SS: Characteristics of GABA release induced by free radicals in mouse hippocampal slices. Neurochem Res 2007 (in press )
- Fedele E, Jin Y, vernier G. Raitcri M: In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway. Br J Pharmacol 1996; 119: 590-4 https://doi.org/10.1111/j.1476-5381.1996.tb15713.x
- Yaksh TL, Rudy TA: Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976; 17: 1031-6 https://doi.org/10.1016/0031-9384(76)90029-9
- Wilcox GL. Seybold V; Pharmacology of spinal af ferent processing. In: Anesthesia : biologic foundations. Edited by Yaksh TL, Lynch III C, Zapel WM, Maze M, Biebuyck JF, Saidrnan U : Philadelphia. Lippincott-Raven Publishers . 1997, pp 557-76
- Bca vo JA, Reifsnyder DH: Primary sequence of cyclic nucleotide phosphodies terase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 1990; 11: 150-5 https://doi.org/10.1016/0165-6147(90)90066-H
- Uckert S, Hedlund P, Andersson KE, Truss MC, Jonas U. Stief CG: Update on phosphodies terase (PDE) isoenzymes as pharmacologic targets in urology: present and future. Eur Urol 2006; 50: 1194-207 https://doi.org/10.1016/j.eururo.2006.05.025
- Eaton MJ. Martinez MA. Kannally S: A single intrathecal injection of GABA permanently reverses neuropathic pain after nerve injury. Brain Res 1999: 835: 334-9 https://doi.org/10.1016/S0006-8993(99)01564-4
- Moore KA, Kohne T, Karchewski LA, Scholz J, Baba H, Woolf CJ: Part ial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Ncurosci 2002; 22: 6724-31 https://doi.org/10.1523/JNEUROSCI.22-15-06724.2002
- Malcangio M, Bowery NG: Gam ma-arninobutyric acid B, but not gamma-aminobutyric acid A recep tor activation, inhibits electrically evoked substance P-like immunoreactivity release from the rat spinal co rd in vitro. J Pharmacol Exp Ther 1993; 266: 1490-6
- Malan TP, Mata HP, Porreca F: Spinal GABA(A) and GABA(B) recep tor pharmacology in a rat model of neuropathic pain. Anesthesiology 2002 ; 96: 1161-7 https://doi.org/10.1097/00000542-200205000-00020
- Sionimski M, Abram SE. Zuniga RE: Intrathecal baclofc n in pain management. Reg Anesth Pain Med 2004; 29: 269-76 https://doi.org/10.1097/00115550-200405000-00014
Cited by
- The role of adrenergic and cholinergic receptors on the antinociception of sildenafil in the spinal cord of rats vol.502, pp.2, 2007, https://doi.org/10.1016/j.neulet.2011.07.030
- Comparison of sildenafil, fluoxetine and its co-administration against chronic constriction injury induced neuropathic pain in rats: An influential additive effect vol.41, pp.10, 2019, https://doi.org/10.1080/01616412.2019.1630091